Candriam Equities L Biotechnology, V - Capitalisation/ LU0317020203 /
| NAV9/6/2024 | Chg.-25.1299 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,217.8201USD | -1.12% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 3.61 | 5.39 | -8.19 | 12.61 | -2.42 | 3.86 | -12.36 | 8.75 | -2.82 | - |
| 2017 | 5.51 | 6.90 | -0.08 | 1.23 | -3.06 | 9.25 | 2.56 | 6.40 | 0.81 | -6.34 | 0.29 | 1.54 | +26.78% |
| 2018 | 6.88 | -4.67 | -1.88 | -3.09 | 4.69 | 0.99 | 4.63 | 4.22 | -2.00 | -13.93 | 4.22 | -8.45 | -10.11% |
| 2019 | 13.27 | 3.46 | -0.54 | -4.84 | -4.71 | 9.42 | -2.29 | -2.34 | -4.19 | 10.53 | 11.85 | 2.47 | +33.93% |
| 2020 | -5.17 | -1.12 | -4.99 | 12.89 | 9.37 | 1.42 | -2.84 | 0.94 | 0.78 | -2.79 | 9.82 | 3.08 | +21.34% |
| 2021 | 1.90 | -2.51 | -4.18 | 2.81 | -2.18 | 6.45 | -1.37 | 4.00 | -4.15 | 0.25 | -4.29 | 2.37 | -1.59% |
| 2022 | -10.77 | -1.96 | 5.73 | -7.54 | -3.35 | 3.08 | 4.65 | 1.14 | -1.90 | 7.00 | 6.18 | -2.79 | -2.30% |
| 2023 | 3.02 | -5.67 | 0.45 | 2.29 | -1.19 | 1.26 | -0.13 | -0.15 | -4.28 | -6.10 | 5.99 | 13.49 | +7.70% |
| 2024 | 1.35 | 1.37 | 0.07 | -6.11 | 4.14 | 5.42 | 6.46 | 1.64 | -4.10 | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.42% | 16.32% | 17.48% | 20.19% | 22.64% |
| Sharpe ratio | 0.70 | 0.61 | 0.94 | -0.04 | 0.33 |
| Best month | +13.49% | +6.46% | +13.49% | +13.49% | +13.49% |
| Worst month | -6.11% | -6.11% | -6.11% | -10.77% | -10.77% |
| Maximum loss | -10.96% | -8.91% | -11.37% | -28.36% | -30.61% |
| Outperformance | -1.00% | - | -1.80% | +3.49% | - |
All quotes in USD
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,207.8201 | +17.32% | +0.47% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,325.4399 | +15.29% | +15.05% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,529.8501 | +13.46% | +11.78% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,991.3800 | +20.66% | +11.51% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 230.6300 | +14.82% | +14.82% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 371.4900 | +14.06% | +15.77% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 341.2200 | +15.90% | +17.90% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 214.2200 | +15.02% | -1.37% | |
| Candriam Equities L Biotechnolog... | reinvestment | 159.7600 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 644.6200 | +18.87% | +6.64% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,065.2002 | +19.70% | +7.94% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,217.8201 | +19.84% | +8.33% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 211.2900 | +16.97% | +0.43% | |
| Candriam Equities L Biotech.R US... | reinvestment | 288.4200 | +20.36% | +10.68% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 220.8700 | +17.96% | +2.92% | |
| Candriam Equities L Biotechnolo... | reinvestment | 905.8300 | +19.30% | +7.95% | |
| Candriam Equities L Biotechnolog... | paying dividend | 827.2000 | +19.26% | +7.85% |
Performance
| YTD | +9.96% | ||
|---|---|---|---|
| 6 Months | +6.53% | ||
| 1 Year | +19.84% | ||
| 3 Years | +8.33% | ||
| 5 Years | +68.57% | ||
| 10 Years | - | ||
| Since start | +121.78% | ||
| Year | |||
| 2023 | +7.70% | ||
| 2022 | -2.30% | ||
| 2021 | -1.59% | ||
| 2020 | +21.34% | ||
| 2019 | +33.93% | ||
| 2018 | -10.11% | ||
| 2017 | +26.78% | ||
